Acceptance or rejection of prophylactic medicine in patients with migraine: a cross-sectional study.
Most patients with two or more migraine attacks per month do not use prophylactic medication. The aim of this study is to investigate how many patients use prophylaxis or would like to use them, and which aspects of migraine contribute to the choice to use prophylactic treatment. In a cross-sectional survey in three general practices, patients were selected who were diagnosed with migraine or had prescriptions for migraine medication. A questionnaire was sent to 283 patients and completed by 166 patients, of whom 15 were excluded. A total of 129 females and 22 males were included (median age 41 years). Most patients had two or more attacks per month (66.2%). Fifty-five per cent of patients with two or more attacks per month wanted to use prophylaxis; only 8% actually used this treatment. To get more insight into the ideas for or against prophylactic use, qualitative research is indicated.
Kol
Carianne M C
CM
Department of Public Health and Primary Care, Leiden University Medical Centre, Leiden, The Netherlands.
Dekker
Frans
F
Neven
Arie Knuistingh
AK
Assendelft
Willem J J
WJ
Blom
Jeanet W
JW
D000328:Adult; D003430:Cross-Sectional Studies; D005194:Family Practice; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000517:prevention & control*; D010342:Patient Acceptance of Health Care; D011788:Quality of Life; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D013997:Time Factors
D017366:Serotonin Receptor Agonists